MetLife Total increased by 1.5% to $342.19B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 8.5%, from $315.47B to $342.19B. Over 5 years (FY 2020 to FY 2025), Total shows relatively stable performance with a 1.6% CAGR.
Changes reflect the scale of the investment portfolio and the firm's capital deployment strategy into debt instruments.
This represents the original cost of debt securities classified as available-for-sale, adjusted for amortization of prem...
Standard metric for financial institutions and insurance companies holding fixed-income portfolios.
other_available_for_sale_debt_securities_amortized_cost_basis| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $307.10B | $310.00B | $310.88B | $313.87B | $299.53B | $302.46B | $306.03B | $304.96B | $307.05B | $306.18B | $300.56B | $300.62B | $303.19B | $309.41B | $307.42B | $315.47B | $321.74B | $324.83B | $337.20B | $342.19B |
| QoQ Change | — | +0.9% | +0.3% | +1.0% | -4.6% | +1.0% | +1.2% | -0.3% | +0.7% | -0.3% | -1.8% | +0.0% | +0.9% | +2.0% | -0.6% | +2.6% | +2.0% | +1.0% | +3.8% | +1.5% |
| YoY Change | — | — | — | — | -2.5% | -2.4% | -1.6% | -2.8% | +2.5% | +1.2% | -1.8% | -1.4% | -1.3% | +1.1% | +2.3% | +4.9% | +6.1% | +5.0% | +9.7% | +8.5% |